1887

Access Microbiology open research platform logo

Volume 6, Issue 11

Epidemiological and virological characteristics of people living with HIV on antiretroviral treatment for more than 6 months in virological failure in Brazzaville, Republic of Congo Open Access

Abstract

Virological failure is one of the main causes of failing to treat, and better management of HIV infection requires understanding and controlling the factors that contribute to this phenomenon. The main objective was to characterize the patients of the active file of the Brazzaville Outpatient Treatment Center in virological failure to identify predictive factors leading to virological failure.

Conducted between June and December 2020, this was a cross-sectional study. Patients enrolled were HIV-1-infected patients from the Brazzaville Outpatient Treatment Center receiving a potent combination therapy for at least 6 months but experiencing virological failure. Viral load was measured using the automated Abbott Real-time HIV-1 m2000rt System. Sociodemographic and clinical data were collected from a computerized patient record software called Santia. For the identification of the independent predictors of virological failure, statistical analysis was performed.

A total of 109 patients with virological failure were recruited. The median age of the patients was 45 years (interquartile range: 37–52 years) and women were more represented (74%). More than half of the patients had World Health Organization stage IV HIV and the median duration of antiretroviral treatment was 96 months. The most followed treatment regimen was AZT+3TC+EFV (or nevirapine) with 48%, while the median viral load was 12985 copies ml.

In our study, we did not identify any sociodemographic or clinical variables predictive of virological failure. However, we felt that it would be desirable to carry out a study with temporal follow-up and the possibility of sequencing in order to identify the different circulating genotypes and resistance mutations.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): Brazzaville , epidemiology , HIV , Republic of Congo , viral load and virological failure
© 2024 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. The Microbiology Society waived the open access fees for this article.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000805.v3
2024-11-11
2024-12-14
Loading full text...

Full text loading...

/deliver/fulltext/acmi/6/11/acmi000805.v3.html?itemId=/content/journal/acmi/10.1099/acmi.0.000805.v3&mimeType=html&fmt=ahah

References

  1. UNAIDS Ending AIDS progress towards the 90–90–90 targets; 2017 https://www.unaids.org/sites/default/files/media_asset/Global_AIDS_update_2017_en.pdf
  2. World Health Organization HIV/AIDS; 2021 https://www.who.int/data/gho/data/themes/hiv-aids accessed 26 June 2021
  3. Ahmed M, Merga H, Jarso H. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study. BMC Infect Dis 2019; 19:305 [View Article] [PubMed]
     [Google Scholar]
  4. UNAIDS Global HIV & AIDS statistics — 2019 fact sheet; 2019 https://www.unaids.org/en/resources/fact-sheet accessed 26 June 2021
  5. POUGET-ABADIE X Caractéristiques épidémiologiques et virologiques des personnes vivant avec le VIH sous traitement antirétroviral depuis plus de six mois en échec thérapeutique. Université de Poitiers, Faculté de Médecine et Pharmacie; 2014
  6. Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin A-G et al. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study. J Antimicrob Chemother 2013; 68:1400–1405 [View Article] [PubMed]
     [Google Scholar]
  7. Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis 2020; 20:460 [View Article] [PubMed]
     [Google Scholar]
  8. Ciaranello AL, Chang Y, Margulis AV, Bernstein A, Bassett IV et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: A systematic review and meta-analysis. Clin Infect Dis 2009; 49:1915–1927 [View Article] [PubMed]
     [Google Scholar]
  9. Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A et al. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines. AIDS Res Hum Retroviruses 2013; 29:242–249 [View Article] [PubMed]
     [Google Scholar]
  10. Salou M, Dagnra AY, Butel C, Vidal N, Serrano L et al. High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo. J Int AIDS Soc 2016; 19:20683 [PubMed]
     [Google Scholar]
  11. Muri L, Gamell A, Ntamatungiro AJ, Glass TR, Luwanda LB et al. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern. AIDS 2017; 31:61–70 [View Article] [PubMed]
     [Google Scholar]
  12. Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One 2015; 10:e0116144 [View Article] [PubMed]
     [Google Scholar]
  13. Hassan AS, Nabwera HM, Mwaringa SM, Obonyo CA, Sanders EJ et al. HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study. AIDS Res Ther 2014; 11:9 [View Article] [PubMed]
     [Google Scholar]
  14. Rupérez M, Pou C, Maculuve S, Cedeño S, Luis L et al. Determinants of virological failure and antiretroviral drug resistance in Mozambique. J Antimicrob Chemother 2015; 70:2639–2647 [View Article] [PubMed]
     [Google Scholar]
  15. Liégeois F, Vella C, Eymard‐Duvernay S, Sica J, Makosso L et al. Virological failure rates and HIV‐1 drug resistance patterns in patients on first‐line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc 2012; 15: [View Article]
     [Google Scholar]
  16. Ndahimana J d, Riedel DJ, Mwumvaneza M, Sebuhoro D, Uwimbabazi JC et al. Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda. Tropical Med Int Health 2016; 21:928–935 [View Article]
     [Google Scholar]
  17. Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014–July 2015. BMC Infect Dis 2017; 17: [View Article]
     [Google Scholar]
  18. Brhane BG, Nibret E, Abay GK. HIV/AIDS treatment failure and its determinant factors among first line HAART patients at felege-hiwot referral hospital, bahir dar, northwest ethiopia. J AIDS Clin Res 2017 [View Article]
     [Google Scholar]
  19. Bayu B, Tariku A, Bulti AB, Habitu YA, Derso T et al. Determinants of virological failure among patients on highly active antiretroviral therapy in University of Gondar Referral Hospital, Northwest Ethiopia: a case-control study. HIV AIDS (Auckl) 2017; 9:153–159 [View Article] [PubMed]
     [Google Scholar]
  20. Ramadhani HO, Thielman NM, Landman KZ, Ndosi EM, Gao F et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis 2007; 45:1492–1498 [View Article]
     [Google Scholar]
  21. Pircher M, Diafouka M, Papuchon J, Recordon-Pinson P, Mahambou DN et al. Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs. AIDS Res Hum Retroviruses 2012; 28:1798–1802 [View Article]
     [Google Scholar]
  22. Malonga GA, Eouani LME, Mokoko JC, Ngakengni NY, Missamou GLE et al. Early diagnosis by PCR of HIV1 in children before 18 months born to HIV-positive mothers in brazzaville. EAST Afr Med J 2019; 96:
     [Google Scholar]
  23. Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets 2011; 11:167–174 [View Article] [PubMed]
     [Google Scholar]
  24. El-Khatib Z, Katzenstein D, Marrone G, Laher F, Mohapi L et al. Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One 2011; 6:e17518 [View Article] [PubMed]
     [Google Scholar]
  25. Got FEB, Recordon-Pinson P, Loubano-Voumbi G, Ebourombi D, Blondot M-L et al. Absence of resistance mutations in the integrase coding region among ART-experienced patients in the Republic of the Congo. Microorganisms 2021; 9:2355 [View Article] [PubMed]
     [Google Scholar]
  26. Lesly Mboussa B, Loukabou Mbongolo NC, Arnold Malonga G. Molecular characterization of HIV-1 among female sex workers (FSWs) in five Departments of the Republic of Congo. Int J Health Sci Res 2023; 13:186–193 [View Article]
     [Google Scholar]
/content/journal/acmi/10.1099/acmi.0.000805.v3
Loading
Epidemiological and virological characteristics of people living with HIV on antiretroviral treatment for more than 6 months in virological failure in Brazzaville, Republic of Congo
Access Microbiology 6, 000805.v3 (2024); https://doi.org/10.1099/acmi.0.000805.v3
/content/journal/acmi/10.1099/acmi.0.000805.v3
/content/journal/acmi/10.1099/acmi.0.000805.v3
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error